Search research articles
Contact Us
Filters
Showing results (141-150 of 381) with videos related to
Page
of 39
Sort By:
Expert Opinion on Drug Safety
|
August 18, 2020
Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis
Francesco Massari, Veronica Mollica, Alessandro Rizzo, et al.
Seminars in Cancer Biology
|
September 18, 2021
Microbiota and prostate cancer
Alessandro Rizzo, Matteo Santoni, Veronica Mollica, et al.
Journal of Clinical Medicine
|
December 17, 2024
Treatment Sequencing and Independent Outcomes of First- and Second-Line Chemotherapy in a Retrospective Series of Patients with Biliary Tract Cancer
Giorgio Frega, Andrea Palloni, Chiara Deiana, et al.
Immunotherapy
|
November 23, 2020
Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysis
Filippo Gustavo Dall'Olio, Alessandro Rizzo, Veronica Mollica, et al.
Expert Review of Medical Devices
|
January 29, 2020
Ablation for the treatment of Brugada syndrome: current status and future prospects
Alessandro Rizzo, Carlo de Asmundis, Pedro Brugada, et al.
Therapeutic Advances in Medical Oncology
|
July 15, 2021
Targeted therapy in <i>SDH-</i>deficient GIST
Margherita Nannini, Alessandro Rizzo, Valentina Indio, et al.
Expert Review of Gastroenterology & Hepatology
|
February 28, 2022
Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY
Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 15, 2021
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials
Francesco Massari, Alessandro Rizzo, Veronica Mollica, et al.
Expert Opinion on Pharmacotherapy
|
August 18, 2021
An up-to-date evaluation of cabozantinib for the treatment of renal cell carcinoma
Andrea Marchetti, Matteo Rosellini, Alessandro Rizzo, et al.
Current Oncology (Toronto, Ont.)
|
May 27, 2022
Genomics and Immunomics in the Treatment of Urothelial Carcinoma
Veronica Mollica, Francesco Massari, Alessandro Rizzo, et al.
Page
of 39
Search research articles
Search
Showing results (141-150 of 381) with videos related to
Sort By:
Page
of 39
Expert Opinion on Drug Safety
|
August 18, 2020
Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis
Francesco Massari, Veronica Mollica, Alessandro Rizzo, et al.
Seminars in Cancer Biology
|
September 18, 2021
Microbiota and prostate cancer
Alessandro Rizzo, Matteo Santoni, Veronica Mollica, et al.
Journal of Clinical Medicine
|
December 17, 2024
Treatment Sequencing and Independent Outcomes of First- and Second-Line Chemotherapy in a Retrospective Series of Patients with Biliary Tract Cancer
Giorgio Frega, Andrea Palloni, Chiara Deiana, et al.
Immunotherapy
|
November 23, 2020
Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysis
Filippo Gustavo Dall'Olio, Alessandro Rizzo, Veronica Mollica, et al.
Expert Review of Medical Devices
|
January 29, 2020
Ablation for the treatment of Brugada syndrome: current status and future prospects
Alessandro Rizzo, Carlo de Asmundis, Pedro Brugada, et al.
Therapeutic Advances in Medical Oncology
|
July 15, 2021
Targeted therapy in <i>SDH-</i>deficient GIST
Margherita Nannini, Alessandro Rizzo, Valentina Indio, et al.
Expert Review of Gastroenterology & Hepatology
|
February 28, 2022
Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY
Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 15, 2021
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials
Francesco Massari, Alessandro Rizzo, Veronica Mollica, et al.
Expert Opinion on Pharmacotherapy
|
August 18, 2021
An up-to-date evaluation of cabozantinib for the treatment of renal cell carcinoma
Andrea Marchetti, Matteo Rosellini, Alessandro Rizzo, et al.
Current Oncology (Toronto, Ont.)
|
May 27, 2022
Genomics and Immunomics in the Treatment of Urothelial Carcinoma
Veronica Mollica, Francesco Massari, Alessandro Rizzo, et al.
Page
of 39